Evidence map›Paper›PMID 21475196›Full record

ArticleNature2011

Streptococcal M1 protein constructs a pathological host fibrinogen network.

Pauline Macheboeuf, Cosmo Buffalo, Chi-yu Fu, Annelies S Zinkernagel, Jason N Cole, John E Johnson, Victor Nizet, Partho Ghosh

Registry-linked trialAbstract read
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02533011 (Heparin Binding Protein), which is not on this map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02533011 completednot on this mapstarted 2015, after this paper: background citation

Heparin Binding Protein (HBP) in Sepsis for the Prediction of Disease Progression

TypeobservationalSponsorChristiana Care Health ServicesRan2015 to 2017Enrolled1,055ConditionsSepsis, Infection, Septic ShockArmsHBP lab test
3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Structural Basis of a Novel Heme Binding Bacterial One-Component Switch.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. M1 protein from group ABlood vessels, thrombosis & hemostasis · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis.International journal of molecular sciences · 2021
    Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Pauline MacheboeufDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, USA.
Cosmo Buffalo
Chi-yu Fu
Annelies S Zinkernagel
Jason N Cole
John E Johnson
Victor Nizet
Partho Ghosh
University of California, San Diego · USScripps Research Institute · USLa Jolla Pharmaceutical (United States) · US

Funding

GENETIC MECHANISMS AND REGULATIONT32GM007240 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMPTON, RANDOLPH Y. · 1985 to 2019
$23.8M
Studies of large and small-scale virus capsid dynamicsR01GM054076 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI JOHNSON, JOHN EMIL · 1995 to 2014
$6.2M
Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
Streptococcus M protein and antibody cross-reactivity in rheumatic feverR21AI071167 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PARTHO · 2007 to 2008
$408k
NIAID NIH HHS R01 AI052453NIAID NIH HHS R01 AI077780NIAID NIH HHS R21 AI071167NIAID NIH HHS R37 AI052453NIGMS NIH HHS R01 GM054076NIGMS NIH HHS R01 GM54076NIGMS NIH HHS T32 GM007240
6 · The paper itself

Abstract

M1 protein, a major virulence factor of the leading invasive strain of group A Streptococcus, is sufficient to induce toxic-shock-like vascular leakage and tissue injury. These events are triggered by the formation of a complex between M1 and fibrinogen that, unlike M1 or fibrinogen alone, leads to neutrophil activation. Here we provide a structural explanation for the pathological properties of the complex formed between streptococcal M1 and human fibrinogen. A conformationally dynamic coiled-coil dimer of M1 was found to organize four fibrinogen molecules into a specific cross-like pattern. This pattern supported the construction of a supramolecular network that was required for neutrophil activation but was distinct from a fibrin clot. Disruption of this network into other supramolecular assemblies was not tolerated. These results have bearing on the pathophysiology of streptococcal toxic shock.

Indexed as

Amino Acid SequenceBacterial ProteinsBinding SitesCrystallography, X-RayFibrinogenHumansModels, MolecularNeutrophil ActivationProtein BindingProtein ConformationShock, SepticStreptococcus pyogenesVirulenceVirulence FactorsBacterial ProteinsFibrinogenVirulence Factors

Identifiers

PMID21475196
PMCPMC3268815
OpenAlexW2079105039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.